Targeting PI3K/Akt/mTOR Signaling in Cancer
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference73 articles.
1. Cellular survival: a play in three Akts;Datta;Genes Dev,1999
2. Ras, PI3K, and mTOR signalling controls tumor cell growth;Shaw;Nature,2006
3. Exploiting the PI3K/Akt pathway for cancer drug discovery;Hennessy;Nat Rev Drug Discov,2005
4. Inhibition of PI3K/Akt signaling: an emerging paradigm for targeted cancer therapy;Chen;Curr Med Chem Anticancer Agents,2005
5. Phosphoinositide kinases;Fruman;Annu Rev Biochem,1998
Cited by 1223 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Metabolism of fatty acid;Metabolomics of Bladder Cancer;2025
2. Elucidating molecular mechanism and chemical space of chalcones through biological networks and machine learning approaches;Computational and Structural Biotechnology Journal;2024-12
3. Sex-dimorphic effects of glucose transporter-2 gene knockdown on hypothalamic primary astrocyte phosphoinositide-3-kinase (PI3K)/protein kinase B (PKB/Akt)/mammalian target of rapamycin (mTOR) cascade protein expression and phosphorylation;Molecular and Cellular Endocrinology;2024-11
4. Regulation of prostate-specific membrane antigen (PSMA) expression in prostate cancer cells after treatment with dutasteride and lovastatin;Neoplasia;2024-11
5. Novel drug delivery systems in colorectal cancer: Advances and future prospects;Pathology - Research and Practice;2024-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3